Rockefeller Capital Management L.P. - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 220 filers reported holding REATA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.91 and the average weighting 0.6%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$666,207
+113200.5%
6,534
+0.9%
0.00%0.0%
Q1 2023$588
+140.0%
6,4740.0%0.00%
+200.0%
Q4 2022$245
-99.8%
6,474
+17.2%
0.00%0.0%
Q3 2022$138,000
-27.7%
5,524
-12.2%
0.00%0.0%
Q2 2022$191,000
-4.5%
6,292
+2.7%
0.00%0.0%
Q1 2022$200,000
+525.0%
6,124
+389.9%
0.00%
Q4 2021$32,000
-90.7%
1,250
-63.7%
0.00%
-100.0%
Q3 2021$345,000
-44.6%
3,439
-22.0%
0.00%
-50.0%
Q2 2021$623,000
+268.6%
4,408
+159.3%
0.00%
+300.0%
Q1 2021$169,000
-19.5%
1,7000.0%0.00%
-50.0%
Q4 2020$210,000
+24.3%
1,700
-2.5%
0.00%0.0%
Q3 2020$169,000
+4125.0%
1,743
+6872.0%
0.00%
Q2 2020$4,000
-33.3%
25
-39.0%
0.00%
Q1 2020$6,000
-40.0%
41
-18.0%
0.00%
Q4 2019$10,000
+150.0%
500.0%0.00%
Q3 2019$4,000500.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$288,821,00055.24%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 100,000$9,970,00015.20%
Tolleson Wealth Management, Inc. 108,000$10,768,0003.25%
MADDEN SECURITIES Corp 34,787$3,468,0002.03%
Biondo Investment Advisors, LLC 101,204$10,090,0002.01%
LBJ Family Wealth Advisors, Ltd. 30,368$3,027,0001.91%
Duquesne Family Office 749,897$74,765,0001.65%
Sofinnova Investments, Inc. 238,520$23,780,0001.43%
Camber Capital Management LP 400,000$39,880,0001.37%
Integral Health Asset Management, LLC 44,000$4,387,0001.25%
View complete list of REATA PHARMACEUTICALS INC shareholders